期刊文献+

水飞蓟素纳米粒载体材料与制备方法的初步筛选 被引量:3

Preliminary study on materials and preparation of silymarin-loaded nanoparticles
在线阅读 下载PDF
导出
摘要 目的 对水飞蓟素纳米粒载体材料和制备方法进行了初步筛选。方法 以平均粒径、包封率、载药量和表面形态作为评价指标,考察了水飞蓟素纳米粒载体材料和制备方法。结果 固体脂质纳米粒(SLN)具有较高的包封率,纳米粒呈片状;乳酸/乙醇酸共聚物(PLGA)纳米粒粒径分布较均匀;纳米脂质体形成较少。结论 选择山榆酸甘油酯作为制备水飞蓟素纳米粒的载体材料,采用高压乳匀法制备水飞蓟素SLN是较为理想的方法。 OBJECTIVE To study the materials and preparation of silymarin-loaded nanoparticles preliminarily. METHODS Materials and preparation of silymarin-loaded nanoparticles were selected by mean diameter, entrapment efficiency, drug loading, and morphology. RESULTS Solid lipid nanoparticles had better entrapment efficiency and it was sheet-shaped. PLGA nanoparticles had narrow size distribution. However, nanoliposomes was hardly formed. CONCLUSIONS Compritol 888 ATO was a good material for preparing silymarin-loaded nanoparticles, and high pressure homogenization may be used to prepare the silymarin-loaded SLN.
出处 《中南药学》 CAS 2004年第5期259-261,共3页 Central South Pharmacy
基金 国家"863"计划项目(2001AA218011) 上海市纳米科技与产业发展促进中心项目(0143nm063)
关键词 固体脂质纳米粒 水飞蓟素 山榆酸甘油酯 高压乳匀法 solid lipid nanoparticles silymarin compritol 888 ATO high pressure homogenization
  • 相关文献

参考文献5

  • 1[1]Muller RH,Mader K,Gohla S .Solid lipid nanoparticles(SLN)for controlled drug delivery-a review of the state of the art[J].Eur J Pharm Biopharm,2000,50(1):161
  • 2[2]Redhead HM,Davis SS,Illum L .Drug delivery in poly(lactide-co-glycolide)nanoparticles surface modified with poloxamer 407 and poloxamer 908:in vitro characterization and in vivo evaluation[J].Journal of Controlled Release,2001,70(3):353
  • 3朱全刚 胡晋红 孙华君.来氟米特脂质体的制备[J].上海医院药学,2000,11(1):35-35.
  • 4[4]Wissing SA,Kayser O,Muller RH.Solid lipid nanoparticles for parenteral drug delivery[J].Adv Drug Deliv Rev,2004,56(9):1257
  • 5[5]Eldem T,Speiser P,Altorfer H.Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy[J].Pharm Res,1991,8(2):178

共引文献2

同被引文献26

  • 1卢懿,侯世祥,陈彤,孙毅毅,杨本霞,袁子雁.硫酸长春新碱传递体的制备及其离体透皮研究[J].中国中药杂志,2005,30(12):900-903. 被引量:11
  • 2丛玉凤,廖克俭,翟玉春.分子模拟在SBS改性沥青中的应用[J].化工学报,2005,56(5):769-773. 被引量:24
  • 3李凌冰,刘华强.阿替洛尔脂质体制备工艺及处方优化研究[J].中南药学,2005,3(4):201-203. 被引量:8
  • 4王小晓,瞿延晖,姚金成,刘巍,谷建云.β-榄香烯诱导人胃癌BAC823细胞凋亡的实验研究[J].中南药学,2005,3(6):329-331. 被引量:9
  • 5LIU J, XIAO Y, ALLEN C. Polymer-drug compatibility : A guide to the development of delivery systems for the anticancer agent, ellipticine [ J]. J Pharm Sci ,2004,93 ( 1 ) : 132 - 143.
  • 6LAVASANIFAR A, SAMUEL J, KWON GS. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly( ethylene oxide)-block-poly (N-hexyl stearate aspartamide) [ J ]. J Control Release, 2002,79 ( 1-3 ) : 165 - 172.
  • 7LIN SY,LEE C J, LIN YY, Drug-polymer interaction affecting the mechanical properties, adhesion strength and release kinetics of piroxicam-loaded Eudragit E films plasticized with different plasticizers[ J ]. J Control Release, 1995,33 (3) :375 - 381.
  • 8NAIR R,NYAMWEYA N,GONEN S,et al. Influence of various drugs on the glass transition temperature of poly (vinylpyrrolidone) :a thermodynamic and spectroscopic investigation[J].Int J Pharm ,2001,225 ( 1-2 ) :83 - 96.
  • 9PUTTIPIPATKHACHORN S, NUNTHANID J, YAMAMOTO K, et al. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films[ J]. J Control Release,2001,75 (1-2) :143 -153.
  • 10WU C,MCGINITY JW. Non-traditional plasticization of polymeric films [ J ]. Int J Pharm, 1999,177 ( 1 ) : 15 - 27.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部